{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:06:19Z","timestamp":1789445179226,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018232","name":"University of Pennsylvania The Orphan Disease Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008045","name":"Mucolipidosis Type IV Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006778","name":"Georgia Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omtm.2025.101479","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T23:07:34Z","timestamp":1745536054000},"page":"101479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring human plasma proteomic variations in mucolipidosis type IV"],"prefix":"10.1016","volume":"33","author":[{"given":"Brendan R.","family":"Tobin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Misko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Miller-Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Sangster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Grishchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4248-0888","authenticated-orcid":false,"given":"Levi B.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101479_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1212\/WNL.59.3.306","article-title":"The neurogenetics of mucolipidosis type IV","volume":"59","author":"Altarescu","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2025.101479_bib2","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000662","article-title":"Cross-sectional Observations on the Natural History of Mucolipidosis Type IV","volume":"8","author":"Misko","year":"2022","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.omtm.2025.101479_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ajmg.1320410310","article-title":"Mucolipidosis type IV: clinical manifestations and natural history","volume":"41","author":"Chitayat","year":"1991","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.omtm.2025.101479_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135944","article-title":"Progress in elucidating pathophysiology of mucolipidosis IV","volume":"755","author":"Misko","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.omtm.2025.101479_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1212\/WNL.51.2.565","article-title":"Mucolipidosis type IV: characteristic MRI findings","volume":"51","author":"Frei","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2025.101479_bib6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1542\/peds.79.6.953","article-title":"Mucolipidosis type IV: clinical spectrum and natural history","volume":"79","author":"Amir","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtm.2025.101479_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00005072-199503000-00002","article-title":"Mucolipidosis IV: morphology and histochemistry of an autopsy case","volume":"54","author":"Folkerth","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.omtm.2025.101479_bib8","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1001\/archneur.1976.00500120032005","article-title":"Mucolipidosis IV. Clinical, ultrastructural, histochemical, and chemical studies of a case, including a brain biopsy","volume":"33","author":"Tellez-Nagel","year":"1976","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.omtm.2025.101479_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ymgme.2013.11.007","article-title":"Quantitative neuroimaging in mucolipidosis type IV","volume":"111","author":"Schiffmann","year":"2014","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtm.2025.101479_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/humu.1115","article-title":"Mucolipidosis type IV: novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population","volume":"17","author":"Bargal","year":"2001","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtm.2025.101479_bib11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/79095","article-title":"Identification of the gene causing mucolipidosis type IV","volume":"26","author":"Bargal","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2025.101479_bib12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0002-9297(07)62941-3","article-title":"Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV","volume":"67","author":"Bassi","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2025.101479_bib13","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/hmg\/9.17.2471","article-title":"Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel","volume":"9","author":"Sun","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101479_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-94-007-0265-3_11","article-title":"Trpml1","volume":"704","author":"Colletti","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omtm.2025.101479_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-4939-9018-4_12","article-title":"TRPML1-\/TFEB-Dependent Regulation of Lysosomal Exocytosis","volume":"1925","author":"Di Paola","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2025.101479_bib16","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1038\/s41467-019-13572-w","article-title":"TRPML1 links lysosomal calcium to autophagosome biogenesis through the activation of the CaMKKbeta\/VPS34 pathway","volume":"10","author":"Scotto Rosato","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2025.101479_bib17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/jcp.21676","article-title":"Chaperone-mediated autophagy is defective in mucolipidosis type IV","volume":"219","author":"Venugopal","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.omtm.2025.101479_bib18","first-page":"1591","article-title":"Impaired myelination and reduced brain ferric iron in the mouse model of mucolipidosis IV","volume":"8","author":"Grishchuk","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.omtm.2025.101479_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40478-014-0133-7","article-title":"Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV","volume":"2","author":"Grishchuk","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.omtm.2025.101479_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/NEN.0b013e3181942cf0","article-title":"Neuropathology of the Mcoln1(-\/-) knockout mouse model of mucolipidosis type IV","volume":"68","author":"Micsenyi","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.omtm.2025.101479_bib21","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/521954","article-title":"Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV","volume":"81","author":"Venugopal","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2025.101479_bib22","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/hmg\/ddab093","article-title":"MCOLN1 gene therapy corrects neurologic dysfunction in the mouse model of mucolipidosis IV","volume":"30","author":"De Rosa","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101479_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030546","article-title":"Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV","volume":"11","author":"Misko","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.omtm.2025.101479_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/biom13071139","article-title":"The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential","volume":"13","author":"Yang","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.omtm.2025.101479_bib25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.neuron.2015.03.033","article-title":"LRP8-Reelin-Regulated Neuronal Enhancer Signature Underlying Learning and Memory Formation","volume":"86","author":"Telese","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2025.101479_bib26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature08874","article-title":"Structural basis for receptor recognition of vitamin-B(12)-intrinsic factor complexes","volume":"464","author":"Andersen","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101479_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jns.2005.03.009","article-title":"Vitamin B12, demyelination, remyelination and repair in multiple sclerosis","volume":"233","author":"Miller","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.omtm.2025.101479_bib28","first-page":"1342","article-title":"Haploinsufficiency of cytosolic serine hydroxymethyltransferase in the Smith-Magenis syndrome","volume":"57","author":"Elsea","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2025.101479_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.omtm.2025.101479_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1215425","article-title":"Brain cell type specific proteomics approach to discover pathological mechanisms in the childhood CNS disorder mucolipidosis type IV","volume":"16","author":"Sangster","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.omtm.2025.101479_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13023-021-01679-7","article-title":"Proteomics analysis of a human brain sample from a mucolipidosis type IV patient reveals pathophysiological pathways","volume":"16","author":"Vardi","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtm.2025.101479_bib32","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/hmg\/ddy182","article-title":"Fingolimod phosphate inhibits astrocyte inflammatory activity in mucolipidosis IV","volume":"27","author":"Weinstock","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101479_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101269","article-title":"A blood-brain barrier-penetrant AAV gene therapy improves neurological function in symptomatic mucolipidosis IV mice","volume":"32","author":"Sangster","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101479_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj2485","article-title":"GABARAP sequesters the FLCN-FNIP tumor suppressor complex to couple autophagy with lysosomal biogenesis","volume":"7","author":"Goodwin","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtm.2025.101479_bib35","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nature07311","article-title":"The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel","volume":"455","author":"Dong","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101479_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109848","article-title":"Lysosomal Zn(2+) release triggers rapid, mitochondria-mediated, non-apoptotic cell death in metastatic melanoma","volume":"37","author":"Du","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2025.101479_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1042\/BJ20121506","article-title":"Zinc-dependent lysosomal enlargement in TRPML1-deficient cells involves MTF-1 transcription factor and ZnT4 (Slc30a4) transporter","volume":"451","author":"Kukic","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.omtm.2025.101479_bib38","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11010-023-04800-5","article-title":"A new perspective on the autophagic and non-autophagic functions of the GABARAP protein family: a potential therapeutic target for human diseases","volume":"479","author":"Chen","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.omtm.2025.101479_bib39","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.tibs.2021.01.004","article-title":"Beyond Autophagy: The Expanding Roles of ATG8 Proteins","volume":"46","author":"Nieto-Torres","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.omtm.2025.101479_bib40","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1096\/fj.201600698R","article-title":"LC3\/GABARAP family proteins: autophagy-(un)related functions","volume":"30","author":"Schaaf","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2025.101479_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092008","article-title":"Atg8-Family Proteins-Structural Features and Molecular Interactions in Autophagy and Beyond","volume":"9","author":"Wesch","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.omtm.2025.101479_bib42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41467-020-20624-z","article-title":"Structural basis of GABARAP-mediated GABA(A) receptor trafficking and functions on GABAergic synaptic transmission","volume":"12","author":"Ye","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2025.101479_bib43","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11940-009-0013-9","article-title":"Stiff person syndrome: advances in pathogenesis and therapeutic interventions","volume":"11","author":"Dalakas","year":"2009","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.omtm.2025.101479_bib44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40478-016-0334-3","article-title":"Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations","volume":"4","author":"Khundakar","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.omtm.2025.101479_bib45","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.nbd.2011.05.022","article-title":"Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease","volume":"43","author":"Tanji","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtm.2025.101479_bib46","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/cercor\/bhx215","article-title":"CNTNAP4 Impacts Epilepsy Through GABAA Receptors Regulation: Evidence From Temporal Lobe Epilepsy Patients and Mouse Models","volume":"28","author":"Shangguan","year":"2018","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.omtm.2025.101479_bib47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/jhg.2010.1","article-title":"A functional analysis of GABARAP on 17p13.1 by knockdown zebrafish","volume":"55","author":"Komoike","year":"2010","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.omtm.2025.101479_bib48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40364-023-00515-3","article-title":"S100A6: molecular function and biomarker role","volume":"11","author":"Wang","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.omtm.2025.101479_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007670","article-title":"Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients","volume":"4","author":"Wei","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101479_bib50","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1007\/s10620-014-3137-z","article-title":"S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer","volume":"59","author":"Zhang","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.omtm.2025.101479_bib51","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3390\/ijms24021341","article-title":"S100A6 Protein-Expression and Function in Norm and Pathology","volume":"24","author":"Lesniak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2025.101479_bib52","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1523\/JNEUROSCI.1800-21.2022","article-title":"Human APOER2 Isoforms Have Differential Cleavage Events and Synaptic Properties","volume":"42","author":"Omuro","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtm.2025.101479_bib53","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.biopha.2014.08.002","article-title":"Association between cytosolic serine hydroxymethyltransferase (SHMT1) gene polymorphism and cancer risk: a meta-analysis","volume":"68","author":"Wang","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omtm.2025.101479_bib54","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12014-024-09480-x","article-title":"Multiplex proteomics identifies inflammation-related plasma biomarkers for aging and cardio-metabolic disorders","volume":"21","author":"Wu","year":"2024","journal-title":"Clin. Proteom."},{"key":"10.1016\/j.omtm.2025.101479_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026332","article-title":"From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay","volume":"6","author":"Kraemer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101479_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105655","article-title":"Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's disease","volume":"166","author":"Galea","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtm.2025.101479_bib57","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/pro.4218","article-title":"PANTHER: Making genome-scale phylogenetics accessible to all","volume":"31","author":"Thomas","year":"2022","journal-title":"Protein Sci."}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T18:52:52Z","timestamp":1759863172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125000749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2329050125000749"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101479","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring human plasma proteomic variations in mucolipidosis type IV","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101479"}}